Hours worked
17500 +
Protocols involved
20 +
Sponsors secured
10 +
Департамент клинических исследований
Департамент клинических исследований
Clinical trials department
Why pharmaceutical companies choose us?
Our approach
Four simple steps for a successful clinical trial startClinical trial feasibility study
Ethics assessment
Patient enrollment channels evaluation
Step-by-step trial planning
Our resources
We are all set for conducting top notch clinical trials
"Big Pharma" trust us
If you are interested in a reliable partner for conducting top notch phase II-III clinical trials on a wide range of nosologies and still do not work with us, please contact us
News
Stay up to date
Participation in the XXXIII National Congress on Respiratory Diseases
Researchers from the OLLA-MED LLC center took part in the national congress dedicated to the diagnosis and treatment of respiratory diseases. During the congress, colleagues exchanged experience on a wide range of interdisciplinary problems and outlined ways for further cooperation.
New vaccine against tuberculosis: we invite volunteers!
Recruitment of patients who have had pulmonary tuberculosis into a clinical trial of the GamTBVac vaccine has begun to evaluate the effectiveness of the vaccine in preventing relapse. Remuneration for participation in the study is possible. Write to us 8 (993) 202 7840 (whatsapp).
Successful completion of the audit
The high professional level of our site was confirmed by an audit of the sponsor of one of the clinical studies conducted in our research center. We thank the auditors for their comments and suggestions, which we will definitely take into account in future work.
Our partners
